Long-term video-EEG monitoring

Rhythmlink Announces New Addition to EMG/NCV Line: The Concentric Needle Family

Retrieved on: 
Friday, October 13, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231011421601/en/
    Rhythmlinks's new Concentric Needle product (Photo: Business Wire)
    The concentric needle is offered in four sizes or gauges, which also vary in needle diameter, length and color, matching currently accepted workflows.
  • The disposable concentric needle pairs with a reusable cable designed specifically to work with Rhythmlink’s needles.
  • The concentric needle family joins other recent product releases, such as Sticky Pad Surface Electrodes formulated for NCV, both with and without a leadwire.
  • Learn more about Rhythmlink’s full line of products at www.Rhythmlink.com and more about the Concentric Needle at www.Rhythmlink.com/Concentric .

NEURELIS ANNOUNCES FOUR POSTER PRESENTATIONS AT THE 75TH ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY

Retrieved on: 
Tuesday, April 25, 2023

These presentations will highlight quality of life, safety of concomitant cannabidiol (CBD) usage, time to treatment, and significant changes in SEIzure InterVAL (SEIVAL).

Key Points: 
  • These presentations will highlight quality of life, safety of concomitant cannabidiol (CBD) usage, time to treatment, and significant changes in SEIzure InterVAL (SEIVAL).
  • The posters will be presented at the 75th Annual Meeting of the American Academy of Neurology (AAN) in Boston, April 22 to 27, in a hybrid format, with participants joining in person, or live online.
  • "Expanding the clinical profile of VALTOCO is integral to our commitment to improve outcomes for patients with seizure clusters," said Enrique Carrazana, M.D., Neurelis Chief Medical Officer.
  • Details of the selected poster presentations are below and available online to review at the American Academy of Neurology Annual Meeting website:
    SEIzure InterVAL (SEIVAL) Between Seizure Clusters and Quality of Life Across Time From a Phase 3 Safety Study of Diazepam Nasal Spray for Seizure Clusters ; Poster #002, Tuesday, April 25th, 5:30 PM - 6:30 PM ET.

Neurovative Diagnostics Announces Partnership with NeuroX

Retrieved on: 
Tuesday, October 25, 2022

ORLANDO, Fla., Oct. 25, 2022 /PRNewswire/ -- Neurovative Diagnostics, a best-in-class industry leader providing in-home EEG testing and Continuous Monitoring services in acute care settings, announced a partnership with NeuroX, a physician-led, global telemedicine company and leading online clinic for neuro-psychology and neuroscience.

Key Points: 
  • ORLANDO, Fla., Oct. 25, 2022 /PRNewswire/ -- Neurovative Diagnostics, a best-in-class industry leader providing in-home EEG testing and Continuous Monitoring services in acute care settings, announced a partnership with NeuroX, a physician-led, global telemedicine company and leading online clinic for neuro-psychology and neuroscience.
  • Dr. Umar Farooq, NeuroX's Medical Director, notes, "Our partnership with Neurovative is another step towards providing high quality and convenient neurological care and remote patient monitoring to our patients.
  • Our partnership with NeuroX is a great example of our evolving healthcare delivery system working towards being more patient-centric."
  • NeuroX, a project of American TelePhysicians Inc., is thrilled to partner with Neurovative Diagnostics, a world-class EEG company, for its Neurology ecosystem in delivering affordable, convenient, and prompt online brain healthcare services at patients' doorsteps".

Researchers at Ben-Gurion University Developed Wearable Device for Predicting Epileptic Seizures

Retrieved on: 
Tuesday, September 29, 2020

BEER-SHEVA, Israel, Sept. 29, 2020 /PRNewswire/ -- Researchers at Ben-Gurion University of the Negev (BGU) developed Epiness, a new, first of its kind device for detecting and predicting epileptic seizures based on proprietary machine-learning algorithms.

Key Points: 
  • BEER-SHEVA, Israel, Sept. 29, 2020 /PRNewswire/ -- Researchers at Ben-Gurion University of the Negev (BGU) developed Epiness, a new, first of its kind device for detecting and predicting epileptic seizures based on proprietary machine-learning algorithms.
  • Up to 30% of patients do not adequately respond to anti-epileptic drugs and live under constant fear of impending seizures.
  • The device combines a wearable EEG device with state-of-the-art software that minimizes the number of necessary EEG electrodes and optimizes electrode placement on the scalp.
  • "Epileptic seizures expose epilepsy patients to various preventable hazards, including falls, burns and other injuries," said Dr. Oren Shriki.

Methodist University Hospital Is First In The World To Participate In Groundbreaking EEG Study For Inpatients That Improves Brain Monitoring During the COVID-19 Crisis

Retrieved on: 
Tuesday, August 4, 2020

MEMPHIS, Tenn., Aug. 4, 2020 /PRNewswire/ -- Methodist Le Bonheur Healthcare (MLH) is the first hospital system globally to participate in a landmark study using a first-of-its-kind EEG device.

Key Points: 
  • MEMPHIS, Tenn., Aug. 4, 2020 /PRNewswire/ -- Methodist Le Bonheur Healthcare (MLH) is the first hospital system globally to participate in a landmark study using a first-of-its-kind EEG device.
  • EEG tests are conducted to detect problems in the brain that may be associated with certain brain disorders such as seizures, tumors or strokes.
  • A typical EEG test consists of multiple electrodes attached to a patient's scalp with adhesive.
  • An EEG technician at Methodist University can now be more productive and perform more EEGs in a day.

Nihon Kohden Responds to Market Needs with New Premium Disposable Gold Cup EEG Electrodes to Ensure High Quality Signals During COVID-19 Pandemic

Retrieved on: 
Wednesday, April 15, 2020

Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the release of a new Premium Disposable Gold Cup EEG Electrode to the healthcare community.

Key Points: 
  • Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the release of a new Premium Disposable Gold Cup EEG Electrode to the healthcare community.
  • The disposable electroencephalogram (EEG) electrodes help healthcare workers prevent cross contamination between patients while maintaining high quality EEG signals.
  • Gold cup electrodes are preferred for EEG measurements because they offer superior recordings while limiting contaminating noise that can impede the test.
  • With the Premium Disposable Gold Cup EEG Electrodes, we can help protect both patients and healthcare providers.